Skip to main content
SpringerLink
Log in
Book cover

Oncologic Breast Surgery pp 23–46Cite as

The Pathology of Breast Cancer

  • Chapter

  • 1736 Accesses

Part of the book series: Updates in Surgery ((UPDATESSURG))

Abstract

Infiltrating breast carcinoma is the most common cancer in women, accounting for 23% of all cancers in women. Its incidence increases rapidly with age and varies 10-fold worldwide, being high in Europe, North America and Australia, and low in sub-Saharan Africa and in southern and eastern Asia (including Japan).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Suzuki R, Orsini N, Mignone L et al (2008) Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status–a meta-analysis of epidemiological studies. Int J Cancer 122:1832–1841

    Article  CAS  PubMed  Google Scholar 

  2. Collishaw N, Boyd NF, Hammond SK et al (2009) Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk. Ontario Tobacco Research Unit: Toronto, Canada

    Google Scholar 

  3. Su X, Hankinson SE, Clevenger CV et al (2009) Energy balance, early life body size, and plasma prolactin levels in postmenopausal women. Cancer Causes Control 20:253–262

    Article  PubMed Central  PubMed  Google Scholar 

  4. Marchbanks PA, McDonald JA, Wilson HG et al (2002) Oral contraceptives and the risk of breast cancer. N Engl J Med 346:2025–2032

    Article  CAS  PubMed  Google Scholar 

  5. Collaborative Group of Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350:1047–1059

    Article  Google Scholar 

  6. London SJ, Connolly JL, Schnitt SJ et al (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941–944

    Article  CAS  PubMed  Google Scholar 

  7. Page DL, Rogers LW (1992) Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 23:1095–1097

    Article  CAS  PubMed  Google Scholar 

  8. Schnitt SJ (2003) Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 27:836–841

    Article  PubMed  Google Scholar 

  9. Jara-Lazaro AR, Tse GM, Tan PH (2009) Columnar cell lesions of the breast: an update and significance on core biopsy. Pathology 41:18–27

    Article  PubMed  Google Scholar 

  10. El-Sayed ME, Rakha EA, Reed J et al (2008) Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology 53:650–657

    Article  CAS  PubMed  Google Scholar 

  11. Khalifeh IM, Albarracin C, Diaz LK et al (2008) Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Am J Surg Pathol 32:544–552

    Article  PubMed  Google Scholar 

  12. Mulligan AM, O’Malley FP (2007) Papillary lesions of the breast: a review. Adv Anat Pathol 14:108–119

    Article  PubMed  Google Scholar 

  13. O’Malley FP (2010) Lobular neoplasia; morphology, biologic potential and management in core biopsies. Mod Pathol 23:S14–S25

    Article  Google Scholar 

  14. Da Silva L, Parry S, Reid L et al (2008) Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 32:773–783

    Article  PubMed  Google Scholar 

  15. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijer M (eds) (2012) WHO classification of tumours of the breast. 4th Edition. International Agency for Research on Cancer, Lyon, France

    Google Scholar 

  16. Jensen RA, Page DL (2003) Ductal carcinoma in situ of the breast: impact of pathology on therapeutic decisions. Am J Surg Pathol 27:828–831

    Article  PubMed  Google Scholar 

  17. Pinder SE, Duggan C, Ellis IO et al (2010) A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer 103:94–100

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Allred DC, Bryant J, Paik S et al (2002) Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: Findings from the NSABP protocol B-24. Breast Cancer Res Treat 76:A30

    Google Scholar 

  19. Hannemann J, Velds A, Halfwerk JB et al (2006) Classification of ductal carcinoma in situ by gene expression profiling. Breast Cancer Res 8:R61

    Article  PubMed Central  PubMed  Google Scholar 

  20. Etzell JE, DeVries S, Chew K et al (2001) Loss of chromosome 16q in lobular carcinoma in situ. Human Pathol 32:292–296

    Article  CAS  Google Scholar 

  21. Droufakou S, Deshmane V, Roylance R et al (2001) Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.Int J Cancer 92:404–408

    Article  CAS  PubMed  Google Scholar 

  22. Simpson PT, Reis-Filho JS, Lambros MB et al (2008) Molecular profiling pleomorphic lobular carcinoma of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 215:231–244

    Article  CAS  PubMed  Google Scholar 

  23. Kollias J, Elston CW, Ellis O et al (1997) Early-onset breast cancer: histopathological and prognostic considerations. Br J Cancer 75:1318–1323

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Du Toit RS, Locker AP, Ellis IO et al (1989) Invasive lobular carcinomas of the breast: the prognosis of histopathological subtypes. Br J Cancer 60:605–609

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Rakha EA, Patel A, Powel DG et al (2010) Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. Am J Surg Pathol 34:1472–1479

    Article  PubMed  Google Scholar 

  26. Cabral AH, Recine M, Paramo JC et al (2003) Tubular carcinoma of the breast: an institutional experience and review of the literature. Breast J 4:298–301

    Article  Google Scholar 

  27. Diab SG, Clark GM, Osborne CK et al (1999) Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 17:1442–1448

    CAS  PubMed  Google Scholar 

  28. Page DL, Dixon JM, Anderson TJ et al (1983) Invasive cribriform carcinoma of the breast. Histopathology 7:525–536

    Article  CAS  PubMed  Google Scholar 

  29. Ridolfi RL, Rosen PP, Port A et al (1977) Medullary carcinoma of the breast: a clinicopathologic study with 10-year follow-up. Cancer 40:1365–1385

    Article  CAS  PubMed  Google Scholar 

  30. Siriaunkgul S, Tavassoli FA (1993) Invasive micropapillary carcinoma of the breast. Mod Pathol 6:660–662

    CAS  PubMed  Google Scholar 

  31. Yu JI, Choi DH, Park W et al (2010) Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study. Breast 19:231–237

    Article  CAS  PubMed  Google Scholar 

  32. Tse GM, Tan PH, Putti TC et al (2006) Metaplastic carcinoma of the breast: a clinicopathological review. J Clin Pathol 59:1079–1083

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Reis-Filho JS, Milanezi F, Steele D et al (2006) Metaplastic breast carcinomas are basal-like tumours. Histopathology 49:10–21

    Article  CAS  PubMed  Google Scholar 

  34. O’Malley FP, Bane AL (2008) An update on apocrine lesions of the breast. Histopathology 52:3–10

    Article  CAS  Google Scholar 

  35. Patey DH, Scarff RW (1928) The position of histology in the prognosis of carcinoma of the breast. Lancet 1:801–804

    Article  Google Scholar 

  36. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with a long-term followup. Histopathology 19:403–410

    Article  CAS  PubMed  Google Scholar 

  38. Carter GL, Allen C, Henson DR (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181–187

    Article  CAS  PubMed  Google Scholar 

  39. Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival on nodenegative breast cancer. N Engl J Med 364:412–421

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575

    Article  CAS  PubMed  Google Scholar 

  41. Lee AH, Pinder SE, Macmillan RD et al (2006) Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 42:357–362

    Article  CAS  PubMed  Google Scholar 

  42. Clarke RB (2003) Steroid receptors and proliferation in the human breast. Steroids 68:789–794

    Article  CAS  PubMed  Google Scholar 

  43. Harvey JM, Clark GM, Osborne CK et al (1999) Estrogen receptors status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474–1481

    CAS  PubMed  Google Scholar 

  44. Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology/College of American Pathologists guidelines recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134:907–922

    PubMed Central  PubMed  Google Scholar 

  45. Dowsett M, Nielsen TO, A’Hern R et al (2011) Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer Working Group. J Natl Cancer Inst 103:1656–1664

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Yerushalmi R, Woods R, Ravdin PM et al (2010) Ki67 in breast cancer: prognostic and pre-dictive potential. Lancet Oncol 11:174–183

    Article  CAS  PubMed  Google Scholar 

  47. Jones RL, Salter J, A’Hern R et al (2010) Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 119:315–323

    Article  CAS  PubMed  Google Scholar 

  48. Goldhirsch A, Ingle JN, Gelber RD et al (2009) Thresholds for therapies: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009. Ann Oncol 20:1319–1329

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22:1736–1747

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Wolff AC, Hammond ME, Schwartz JN et al (2007) American Society of Clinical Oncology/College of American Pathologists guidelines recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118–145

    Article  CAS  PubMed  Google Scholar 

  51. Curigliano G, Viale G, Bagnardi V et al (2009) Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer. J Clin Oncol 27:5693–5699

    Article  PubMed  Google Scholar 

  52. Van de Vijver MJ, He YD et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009

    Article  PubMed  Google Scholar 

  53. Tang G, Shak S, Paik S et al (2011) Comparison of the prognostic and predictive utilities of the 21-gene recurrence score assay and adjuvant for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20. Breast Cancer Res Treat 127:133–142

    Article  PubMed  Google Scholar 

  54. Flagiello D, Gerbault-Seureau M, Sastre-Garau X et al (1998) Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer. Genes Chromosomes Cancer 23:300–306

    Article  CAS  PubMed  Google Scholar 

  55. Lopez-Garcia MA, Geyer FC, Natrajan R et al (2010) Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas. J Pathol 222:64–75

    CAS  PubMed  Google Scholar 

  56. Berx G, Cleton-Jansen AM, Nollet F et al (1995) E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107–6115

    CAS  PubMed Central  PubMed  Google Scholar 

  57. Weigelt B, Geyer FC, Natrajan R et al (2010) The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade-and molecular subtype-matched invasive ductal carcinomas of no special type. J Pathol 220:45–57

    Article  CAS  PubMed  Google Scholar 

  58. Persson M, Andren Y, Mark J et al (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 106:18740–18744

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Marchio C, Iravani M, Natrajan R et al (2009) Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components. J Pathol 218:301–315

    Article  CAS  PubMed  Google Scholar 

  60. Lacroix-Triki M, Suarez PH, Mackay A et al (2010) Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type. J Pathol 222:282–298

    Article  CAS  PubMed  Google Scholar 

  61. Perou CM, Sorlie T, Elsen MB et al (2000) Molecular portraits of human breast cancer. Nature 406:747–752

    Article  CAS  PubMed  Google Scholar 

  62. Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifentreated, node-negative breast cancer. N Engl J Med 351:2817–2826

    Article  CAS  PubMed  Google Scholar 

  63. Iwamoto T, Bianchini G, Booser D et al (2011) Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J Natl Cancer Inst 103:264–272

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathological Sciences and Public Health, Pathological Anatomy and Histopathology, Politechnic University of Marche, Ancona, Italy

    Alfredo Santinelli

Authors
  1. Alfredo Santinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tommasina Biscotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alfredo Santinelli .

Editor information

Editors and Affiliations

  1. Department of Surgery Breast Surgery Unit, Ospedali Riuniti University Hospital, Ancona, Italy

    Carlo Mariotti

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Santinelli, A., Biscotti, T. (2014). The Pathology of Breast Cancer. In: Mariotti, C. (eds) Oncologic Breast Surgery. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5438-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5438-7_2

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5437-0

  • Online ISBN: 978-88-470-5438-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation